Clinical trial
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive…
NCT00351299 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00351299 |
|---|---|
| Title | Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium |
| Official title | Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Delirium, Agitation |
| Intervention type | Drug, Other |
| Interventions | Dexmedetomidine, Standard of Care |
| Enrollment | 53 |
| Start date | Jan 1, 2006 |
| Primary completion | Oct 1, 2012 |
| Completion | Oct 1, 2012 |
| First posted | Jul 12, 2006 |
| Last update posted | Jun 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: